ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 410

Correlation of  Carotid Intima Media Thickness With Interleukin-6, Tumor Necrosis Factor-α and Anti-Cyclic Citrullinated Peptides In Rheumatoid Arthritis

Lourdes Nuñez Atahualpa1, Mauricio Figuroa Sanchez1, Daniel Alberto Rocha Muñoz2, Raul Vargas Ramirez3, Beatriz Teresita Martin Marquez4, Jorge Ivan Gamez Nava5, Laura González López6, Erika Martínez García3, Esther Sanchez Corona3, Marcelo Petri4, Rosa Navarro Hernandez3, Veronica Gonzalez Diaz7, Jorge Aguilar Arreola8, Ana Guisllaine Bernard Medina9, Alejandra Nuñez Atahualpa10, Javier Andrade Garduño10, Eduardo Gomez Bañuelos3 and Monica Vazquez Del Mercado4,8, 1Radiology, Hospital Civil Fray Antonio Alcalde, Guadalajara, Mexico, 2Unidad de Investigación en Epidemiología Clínica del Hospital de Especialidades Centro Médico Nacional de Occidente, IMSS, Guadalajara, Jalisco, Mexico, 3CUCS, Universidad de Guadalajara, Instituto de Investigación en Reumatología y del Sistema Músculo Esquelético,, Guadalajara, Mexico, 4Instituto de Investigación en Reumatología y del Sistema Músculo Esquelético, Universidad de Guadalajara, Guadalajara, Mexico, 5Unidad de Investigación en Epidemiología Clínica, Hospital de Especialidades Centro Médico Nacional de Occidente., Guadalajara, Jalisco, Mexico, 6Medicina Interna-Reumatología, Departamento de Medicina Interna-Reumatología, Hospital General Regional 110, Instituto Mexicano del Seguro Social., Guadalajara, Jalisco, Mexico, 7Reumatologia, Antiguo Hospital Civil de Guadalajara - Fray Antonio Alcalde, Guadalajara, Mexico, 8Rheumatology, Hospital Civil Dr Juan I Menchaca, Guadalajara, Mexico, 9Rheumatology, Hospital Civil Fray Antonio Alcalde, Guadalajara, Mexico, 10Universidad Autónoma de Guadalajara, Guadalajara, Mexico

Meeting: 2013 ACR/ARHP Annual Meeting

Keywords: anti-CCP antibodies, interleukins (IL), intima medial thickness and rheumatoid arthritis (RA)

  • Tweet
  • Email
  • Print
Session Information

Title: Rheumatoid Arthritis - Clinical Aspects I: Comorbidities in Rheumatoid Arthritis

Session Type: Abstract Submissions (ACR)

Background/Purpose: The main cause of death in rheumatoid arthritis patients are cardiovascular events which cannot be entirely explained by traditional risk factors, suggesting, that systemic inflammation may accelerate them.Anti-cyclic citrullinated peptides (Anti-CCP) antibodies are well known as predictors and markers of clinical activity in RA. Cytokines play an important role in RA. It has been shown that carotid intima media thickness (IMT) values are higher in patients positive for anti-CCP positive.

The aim of this work is to evaluate the relationship of interleukin-6 (IL-6), Tumor Necrosis Factor α (TNF-α), anti-CCP titers and carotid IMT in patients with RA evaluated by bilateral carotid ultrasound.

Methods: Cross-sectional study. The study population was recruited from 2010 to 2012 and included patients with RA of 18 years or older who met the ACR criteria (1987). For the controls we included blood donators matched by gender and by age range. The exclusion criteria for both groups were history of ischemic cardiovascular disease (CVD), hypertension, diabetes mellitus type II, thyroid disease, liver disease, renal impairment, malignancy, dyslipidemia and premature menopause. We also excluded patients treated with high doses of steroids (>10 mg/day).  RA disease activity was measured by the Disease Activity Score 28 (DAS28). Carotid IMT was measured using a high-resolution B-mode ultrasound with a 12-MHz transducer.  Both left and right carotid arteries were examined. All measurements were performed by a single operator. Anti-CCP and other laboratory measurements: ESR, mm/h was measured using the Winthrobe method; hs-CRP levels were calculated by the nephelometric method and expressed as milligrams per liter. Triglycerides, HDL-cholesterol and LDL-cholesterol were measured and expressed as milligrams per deciliter.  Serum was obtained and stored at -70°C for determination of anti-CCP antibodies, IL-6 and TNFα by ELISA. Statistical analysis. Variables were tested for normality using the Kolmogorov-Smirnov test. Student’s t-test or Mann–Whitney U-test was applied for comparison between continuous variables, as well as chi-square or Fisher’s exact test for categorical variables. Multiple regression analysis was performed to assess independent associations between carotid IMT and various clinical and laboratory factors that had p<0.2. All data were analyzed using SPSS 8.0 software, considering a two-tailed level of p<0.05 statistically significant for univariate and multivariate analysis.

Results: Correlation coefficients between carotid IMT and characteristics of the evaluated groups showed a r and p values of 0.319 and 0.02 for age, TNF-α  0.791 and <0.001, IL-6 0.794 and <0.001, anti-CCP 0.539 and <0.001. It was also found an increased carotid IMT between blood donors and RA patients of 61.3 vs 90% (<0.001). The patients were classified as negative or positive for anti-CCP antibodies and we found an association of increased carotid IMT with higher anti-CCP titers (p<0.001).

Conclusion: Pro-inflammatory cytokines are highly correlated with the presence of anti-CCP antibodies and carotid IMT in RA patients.


Disclosure:

L. Nuñez Atahualpa,
None;

M. Figuroa Sanchez,
None;

D. A. Rocha Muñoz,
None;

R. Vargas Ramirez,
None;

B. T. Martin Marquez,
None;

J. I. Gamez Nava,
None;

L. González López,
None;

E. Martínez García,
None;

E. Sanchez Corona,
None;

M. Petri,
None;

R. Navarro Hernandez,
None;

V. Gonzalez Diaz,
None;

J. Aguilar Arreola,
None;

A. G. Bernard Medina,
None;

A. Nuñez Atahualpa,
None;

J. Andrade Garduño,
None;

E. Gomez Bañuelos,
None;

M. Vazquez Del Mercado,
None.

  • Tweet
  • Email
  • Print

« Back to 2013 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/correlation-of-carotid-intima-media-thickness-with-interleukin-6-tumor-necrosis-factor-%ce%b1-and-anti-cyclic-citrullinated-peptides-in-rheumatoid-arthritis/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology